Novalent Biotech
Greensboro, US · Delaware corporation
Founders & leadership
BM
Bill MassaNamed on SEC filing
WT
Wayne ThompsonNamed on SEC filing
KP
Kevin ParrishNamed on SEC filing
AO
Alex OvcharNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$11M disclosed across 1 round · 2021
▶$11MraisedNov 2021 · 712 investors · BiotechnologyRule 506(c)
▶$11MraisedNov 2021 · 712 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bill MassaExecutive Officer, Director
- Wayne ThompsonExecutive Officer
- Kevin ParrishExecutive Officer, Director
- Alex OvcharExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- Minimum investment
- $10K
- Sales commissions
- $990K
- Placement agents
- OpenDeal Broker LLC
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Novalent Biotech raised?
- Novalent Biotech has disclosed $11M raised across 1 round.
- Where is Novalent Biotech headquartered?
- Novalent Biotech is headquartered in Greensboro, US.